Gastrointestinal Stromal Tumors Clinical Trials

21 recruiting

Gastrointestinal Stromal Tumors Trials at a Glance

22 actively recruiting trials for gastrointestinal stromal tumors are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Phase 2 with 7 trials, with the heaviest enrollment activity in Seoul, Guangzhou, and Beijing. Lead sponsors running gastrointestinal stromal tumors studies include Asan Medical Center, Xinhua Zhang, MD, and Peking University People's Hospital.

Browse gastrointestinal stromal tumors trials by phase

Treatments under study

About Gastrointestinal Stromal Tumors Clinical Trials

Looking for clinical trials for Gastrointestinal Stromal Tumors? There are currently 21 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Gastrointestinal Stromal Tumors trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Gastrointestinal Stromal Tumors clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 22 trials

Recruiting
Phase 2

Rivoceranib Plus Paclitaxel in Patients With Gastrointestinal Stromal Tumor

Gastrointestinal Stromal Tumors
Asan Medical Center48 enrolled1 locationNCT05905887
Recruiting
Phase 2

GIST Oral Paclitaxel(Liporaxel)

Gastrointestinal Stromal Tumors
Asan Medical Center28 enrolled1 locationNCT06326346
Recruiting
Phase 2

The Efficacy and Safety of Temozolomide in SDH-deficient GIST

Gastrointestinal Stromal Tumors
Asan Medical Center29 enrolled1 locationNCT05661643
Recruiting
Phase 1

Neoadjuvant Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor

Gastrointestinal Stromal Tumors
University of California, San Diego18 enrolled1 locationNCT07171203
Recruiting
Phase 2

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

Carcinoma, Small CellNeuroendocrine TumorsGastrointestinal Stromal Tumors+11 more
Centre Oscar Lambret88 enrolled3 locationsNCT05500391
Recruiting
Phase 2

Imatinib TDM in GIST

Gastrointestinal Stromal Tumors
Reema A. Patel28 enrolled1 locationNCT05493215
Recruiting
Not Applicable

RCT of EFTR Versus STER for GIST Treatment

GISTSmall Size Gastrointestinal Stromal Tumors
Chinese University of Hong Kong136 enrolled4 locationsNCT07411118
Recruiting

Integrated Cancer Repository for Cancer Research

Breast CancerLiver CancerEsophageal Cancer+47 more
University of Nebraska999,999 enrolled45 locationsNCT02012699
Recruiting
Phase 1

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Gastrointestinal Stromal Tumors
Novelty Nobility, Inc.67 enrolled5 locationsNCT06805825
Recruiting
Phase 2

ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST

Gastrointestinal Stromal Tumors
University of Miami48 enrolled1 locationNCT05366816
Recruiting
Phase 2

5 Years of Adjuvant Imatinib in Patients With Gastrointestinal Stromal Tumor With a High Risk

Gastrointestinal Stromal Tumors
Asan Medical Center35 enrolled1 locationNCT05385549
Recruiting

Observational Registry Data on GIST Patients

Gastrointestinal Stromal Tumors
National Health Research Institutes, Taiwan3,000 enrolled1 locationNCT03602092
Recruiting

Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA

Unresectable Solid TumorGastrointestinal Stromal TumorsRecurrent Metastatic Malignant Neoplasm
Xinhua Zhang, MD74 enrolled1 locationNCT05461664
Recruiting

The Correlation Between Ripretinib Exposure and the Efficacy and Safety in Patients with Advanced GISTs

Gastrointestinal Stromal Tumors
First Affiliated Hospital, Sun Yat-Sen University60 enrolled1 locationNCT06431451
Recruiting

A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors

Unresectable Solid TumorGastrointestinal Stromal TumorsRecurrent Metastatic Malignant Neoplasm
Xinhua Zhang, MD74 enrolled1 locationNCT05464875
Recruiting

Second-line Pharmacotherapy Patterns and Outcomes of Advanced Gastrointestinal Stromal Tumor: A Real-world Study

Gastrointestinal Stromal Tumors
Xinhua Zhang, MD100 enrolled8 locationsNCT05440357
Recruiting

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

Neuroendocrine NeoplasmParagangliomaPheochromocytoma+23 more
Universidad Nacional Autonoma de Mexico750 enrolled3 locationsNCT06523582
Recruiting
Not Applicable

Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the Treatment of Unresectable Advanced GIST

Gastrointestinal Stromal Tumors
First Affiliated Hospital of Chongqing Medical University32 enrolled1 locationNCT06507683
Recruiting

A Cohort Study on the Safety of Laparoscopic Resection of 5cm or Larger Gastric Gastrointestinal Stromal Tumors

Gastrointestinal Stromal Tumors
Fujian Medical University194 enrolled1 locationNCT05938309
Recruiting

Clinical Research of Drug Holiday Based on MRD Detection in GIST Patients at High Risk of Recurrence

Gastrointestinal Stromal Tumors
Peking University People's Hospital40 enrolled1 locationNCT05867901